Gene expression profiling and protein–protein network analysis revealed prognostic hub biomarkers linking cancer risk in type 2 diabetic patients

• Published in: Scientific reports 2023-12, Vol.13 (1), p.22605-22605, Article 22605
• Main Authors: Kasera, Harshita, Shekhawat, Rajveer Singh, Yadav, Pankaj, Singh, Priyanka
• Format: Article
• Language: English
• Subjects: 631/553; 631/553/2490; 631/67; Biomarkers; Cancer; Cell cycle; Computational Biology; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - genetics; Diabetes Mellitus, Type 2 - metabolism; Epidemiology; Gene expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genetic analysis; Genetic factors; Genetic Markers; Health risks; Humanities and Social Sciences; Humans; Immune system; Leukocytes (mononuclear); Leukocytes, Mononuclear - metabolism; Liver cancer; Morphogenesis; multidisciplinary; Neoplasms - genetics; Pancreatic cancer; Peripheral blood mononuclear cells; Prognosis; Protein turnover; Proteins; Science; Science (multidisciplinary)
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-49715-9

Type 2 diabetes mellitus (T2DM) and cancer are highly prevalent diseases imposing major health burden globally. Several epidemiological studies indicate increased susceptibility to cancer in T2DM patients. However, genetic factors linking T2DM with cancer have been poorly studied. In this study, we followed computational approaches using the raw gene expression data of peripheral blood mononuclear cells of T2DM and cancer patients available in the gene expression omnibus (GEO) database. Our analysis identified shared differentially expressed genes (DEGs) in T2DM and three common cancer types, namely, pancreatic cancer (PC), liver cancer (LC), and breast cancer (BC). The functional and pathway enrichment analysis of identified common DEGs highlighted the involvement of critical biological pathways, including cell cycle events, immune system processes, cell morphogenesis, gene expression, and metabolism. We retrieved the protein–protein interaction network for the top DEGs to deduce molecular-level interactions. The network analysis found 7, 6, and 5 common hub genes in T2DM vs. PC, T2DM vs. LC, and T2DM vs. BC comparisons, respectively. Overall, our analysis identified important genetic markers potentially able to predict the chances of PC, LC, and BC onset in T2DM patients.